Navigation Links
Ron Jellison appointed Head of KMC Systems
Date:7/31/2013

MERRIMACK, N.H., July 31, 2013 /PRNewswire/ -- Ron Jellison was appointed Vice President and General Manager of KMC Systems, a leading medical equipment manufacturer and a division of Elbit Systems of America, LLC effective July 1, 2013.  Jellison has been with KMC Systems for nine years as the Director of Business Development, securing new medical device contract manufacturing customers and the growing existing customer relationships.

(Photo: http://photos.prnewswire.com/prnh/20130731/NY56337)

"Jellison's business development experience and industry knowledge made him the natural choice to succeed outgoing General Manager Pat McNallen," commented Raanan Horowitz, President and CEO of Elbit Systems of America. "Pat has provided KMC with superb leadership over the past 25 years, and I have full confidence Ron will build on this strong foundation and lead KMC to additional growth and success.  Pat will now focus on assisting Elbit Systems of America with new business growth areas and will also be available to provide Ron and his team support as needed."

"I see so many great opportunities for KMC in this rapidly changing market," said Jellison. "We will continue to leverage our 30 years of experience and focus our attention in the areas of rapid product development, technology development and expansion into adjacent markets. With KMC Systems continually providing innovative solutions that protect and save lives, it's an exciting time to be in the medical device industry. We are known for our depth of experience and services for the contract development and manufacturing of IVD instrumentation."

Jellison points out that KMC Systems has been achieving high customer satisfaction and year-after-year revenue growth, through such strategies as rapid product development, forward-thinking investments, off-the-shelf technologies and increasing disposable design capabilities.

Off-the-shelf medical device technologies can be integrated into medical programs with precision and speed. "These technologies ultimately benefit our customers with reduced development times and costs, and lower manufacturing costs," stated Jellison. "In other areas such as optics, microfluidics and sensors, we will look for companies that want to partner with KMC so that we can continue to provide innovation to our customers."

KMC has also implemented discreet event simulation allowing systems engineers to explore various concept architectures' ability to meet product requirements. "This provides our OEM customers with a high degree of confidence in how system variables affect product performance," commented Jellison. "This ultimately saves time and costs in medical device development and minimizes design risks early on in the process."

Jellison further stated: "The emergence of point-of-care (POC) instrumentation is driving the need for more focus on the relationship of instrumentation to the disposable or consumable. We are seeing more complex cartridge-based systems that are moving instrument functionalities to a single-test, single-result disposable."

About Elbit Systems of America, LLC

Elbit Systems of America is a leading provider of high performance products and system solutions focusing on the commercial aviation, defense, homeland security, and medical instrumentation markets.  With facilities throughout the United States, Elbit Systems of America is dedicated to supporting those who contribute daily to the safety and security of the United States.  Elbit Systems of America, LLC is wholly owned by Elbit Systems Ltd. (NASDAQ and TASE: ESLT), a global electronics company engaged in a wide range of programs for innovative defense and commercial applications. For additional information, visit: www.elbitsystems-us.com.

About Elbit Systems

Elbit Systems Ltd. is an international defense electronics company engaged in a wide range of programs throughout the world. The Company, which includes Elbit Systems and its subsidiaries, operates in the areas of military and commercial aerospace, land and naval systems, command, control, communications, computers, intelligence surveillance and reconnaissance ("C4ISR"), unmanned aircraft systems ("UAS"), advanced electro-optics, electro-optic space systems, EW suites, airborne warning systems, ELINT systems, data links and military communications systems and radios. The Company also focuses on the upgrading of existing military platforms, developing new technologies for defense, homeland security and commercial aviation applications and providing a range of support services. For additional information, visit: www.elbitsystems.com.

Trademarks

Elbit Systems of America and other trademarks, service marks and logos are registered or unregistered marks of Elbit Systems of America companies in the United States and in foreign countries.  Copyright © 2013 Elbit Systems of America.  All rights reserved.

Forward Looking Statement

This press release contains forward‑looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current fact.  Forward Looking Statements are based on management's expectations, estimates, projections and assumptions.  Forward‑looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended.  These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict.  Therefore, actual future results, performance and trends may differ materially from these forward‑looking statements due to a variety of factors, including, without limitation: scope and length of customer contracts; governmental regulations and approvals; changes in governmental budgeting priorities; general market, political and economic conditions in the countries in which the Company operates or sells, including Israel and the United States among others; differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; and the outcome of legal and/or regulatory proceedings.  The factors listed above are not all-inclusive, and further information is contained in Elbit Systems Ltd.'s latest annual report on Form 20-F, which is on file with the U.S. Securities and Exchange Commission. All forward‑looking statements speak only as of the date of this release. The Company does not undertake to update its forward-looking statements.

Contact: Shari Clarkson I 682-286-2363 I sharon.clarkson@elbitsystems-us.com

 

 

 


'/>"/>
SOURCE Elbit Systems of America
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Herb Baer Appointed President of Polar USA
2. New Executive Vice President Commercial Appointed
3. Israel Makov Appointed Chairman of Sun Pharma Board
4. Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
5. Neal K. Long appointed as Chief Executive Officer at Cardiac Science
6. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
7. Micross Components Appointed as Global Specialist Die Distributor to International Rectifier
8. United Spinal Appointed to U.S. Access Board: Developing Accessible Standards for Medical Diagnostic Equipment
9. Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
10. Doug Pepper appointed as Chief Financial Officer at Cardiac Science
11. Gregory D. Cash Appointed President and Chief Executive Officer of NeuroTherm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... -- Genesis Healthcare Services has merged with Hospice Cloud, a ... Bill Monast , President and CEO of Hospice Cloud ... , executives with Home Health Depot, Inc., the parent ... This acquisition helps Hospice Cloud maintain its position as ... equipment (DME) solutions for the hospice industry. Nathan ...
Breaking Medicine Technology:
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ODH, Inc.™ ... Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s ... PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ODH ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... 2017 , ... With millions of Americans and people worldwide ... all are aware of our options and are empowered with strength and information ... of its newest edition of "Vision and Hearing" in USA Today, that will ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute for Palliative ... in or interested in palliative care education and research. The Symposium, “Innovate. Investigate. ... County San Diego on Sept. 28 and 29, 2017, on the campus of California ...
Breaking Medicine News(10 mins):